ScreenerHero
PRCTPROCEPT BioRobotics Corporation Common Stock
NAS · US · Healthcare · Medical Devices · procept-biorobotics.com
21.68USD-1.05%Mkt Cap: 1.24B $P/E: —

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-…

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$203.17BUSDP/E 37.7
SYK
Stryker Corporation
$126.37BUSDP/E 34.2
MDT
Medtronic plc
$119.49BUSDP/E 25.0
BSX
Boston Scientific Corporation
$73.00BUSDP/E 20.4
SHL
Siemens Healthineers AG
$48.43BUSDP/E 19.9
EW
Edwards Lifesciences Corporation
$51.70BUSDP/E 53.4
DXCM
DexCom, Inc.
$34.85BUSDP/E 36.5
GEHC
GE HealthCare Technologies Inc. Common Stock
$34.04BUSDP/E 17.2
PHIA
Koninklijke Philips N.V.
$25.08BUSDP/E 20.7
PHG
Koninklijke Philips N.V.
$26.80BUSDP/E 20.8
STE
STERIS plc
$23.20BUSDP/E 29.1
ZBH
Zimmer Biomet Holdings, Inc.
$19.26BUSDP/E 24.5
PEN
Penumbra, Inc.
$12.81BUSDP/E 79.7
SNN
Smith & Nephew plc
$12.25BUSDP/E 19.9
SN
Smith & Nephew plc
$11.48BUSDP/E 19.8
GMED
Globus Medical, Inc.
$11.67BUSDP/E 22.2
GKOS
Glaukos Corp
$10.91BUSD
EUZ
Eckert & Ziegler Strahlen-und Medizinte AG
$10.01BUSDP/E 17.1
PODD
Insulet Corporation
$10.28BUSDP/E 27.5
BIO
Bio-Rad Laboratories, Inc. Class A
$10.17BUSDP/E 46.3

Key Statistics

Company
Market Cap1.24B $
Enterprise Value1.04B $
Revenue (TTM)337.34M $
Gross Profit196.23M $
Net Income (TTM)-95.57M $
Revenue/Share5.987 USD
Last Price21.68 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees888
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-17.98
PEG—
EV/EBITDA-9.67
EV/Revenue3.07
P/S3.50
P/B3.49
EPS (TTM)-1.85
EPS (Forward)-1.15
52W Range
16.6719% of range42.43
52W High42.43 USD
52W Low16.67 USD
Profitability
Gross Margin63.70%
Oper. Margin-28.98%
EBITDA Margin-31.77%
Profit Margin-31.02%
ROE-26.12%
ROA-18.81%
Growth
Revenue Growth19.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-48.98M $
CapEx (TTM)9.36M $
FCF Margin-13.98%
FCF Yield-3.80%
Net Debt-150.41M $
Net Debt/EBITDA1.40
Balance Sheet
Debt/Equity0.21
Current Ratio6.55
Quick Ratio5.23
Book Value/Sh5.940 USD
Cash/Share3.979 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.6 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)21.64 USD
Upside (mean)-0.2%
Target Range16.00 USD – 28.00 USD
$16.00-0.2% to mean$28.00
# Analysts11
Ownership
Shares Out.57.27M
Float55.83M
Insiders3.28%
Institutions100.49%
Short Interest
Short Ratio4.8d
Short % Float12.74%
Short % Out.12.38%
Shares Short7.09M
Short (prev mo.)7.65M
Technical
SMA 5020.77 (+4.4%)
SMA 20026.56 (-18.4%)
Beta0.89
S&P 52W Chg18.16%
Avg Vol (30d)1.63M
Avg Vol (10d)1.21M
Technical Indicators
RSI (14)56.1
MACD0.3963
MACD Signal0.0190
MACD Hist.+0.3773
BB Upper23.55 USD
BB Middle19.75 USD
BB Lower15.96 USD
BB Width38.41%
ATR (14)1.346 USD
Vol Ratio (20d)0.48x